Kosuke R. Shima

512 total citations
17 papers, 232 citations indexed

About

Kosuke R. Shima is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Kosuke R. Shima has authored 17 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 4 papers in Oncology. Recurrent topics in Kosuke R. Shima's work include Neuroendocrine Tumor Research Advances (3 papers), Pituitary Gland Disorders and Treatments (3 papers) and Diabetes Treatment and Management (3 papers). Kosuke R. Shima is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Pituitary Gland Disorders and Treatments (3 papers) and Diabetes Treatment and Management (3 papers). Kosuke R. Shima collaborates with scholars based in Japan. Kosuke R. Shima's co-authors include Toshinari Takamura, Shuichi Kaneko, Hirofumi Misu, Naoto Nagata, Akio Fujimura, Hitoshi Ando, Takashi Eto, Masanari Shiramoto, S. Irie and Yumie Takeshita and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Diabetologia.

In The Last Decade

Kosuke R. Shima

17 papers receiving 228 citations

Peers

Kosuke R. Shima
Marcus Simmgen United Kingdom
I‐Ya Chen Taiwan
Shanee Chung Canada
Joel K. Campbell United States
Anna‐Maria Siegert Spain
N. Patano Italy
CJ Strasburger Germany
Zhiyi Song China
Ana Carolina Proença da Fonseca Brazil
Jennifer Strong United Kingdom
Marcus Simmgen United Kingdom
Kosuke R. Shima
Citations per year, relative to Kosuke R. Shima Kosuke R. Shima (= 1×) peers Marcus Simmgen

Countries citing papers authored by Kosuke R. Shima

Since Specialization
Citations

This map shows the geographic impact of Kosuke R. Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke R. Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke R. Shima more than expected).

Fields of papers citing papers by Kosuke R. Shima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke R. Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke R. Shima. The network helps show where Kosuke R. Shima may publish in the future.

Co-authorship network of co-authors of Kosuke R. Shima

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke R. Shima. A scholar is included among the top collaborators of Kosuke R. Shima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke R. Shima. Kosuke R. Shima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nakano, Yujiro, Takeo Tanaka, Kosuke R. Shima, et al.. (2022). Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome. Internal Medicine. 61(24). 3693–3698. 4 indexed citations
2.
3.
Niida, Yo, et al.. (2019). A novel PHEX mutation associated with vitamin D-resistant rickets. Human Genome Variation. 6(1). 9–9. 7 indexed citations
4.
Shima, Kosuke R., Yasuo Sasagawa, Yasuhiko Hayashi, et al.. (2018). Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly. Endocrine Journal. 65(10). 1061–1067. 6 indexed citations
5.
Shima, Kosuke R., Takeshi Futatani, Hiroshi Akahori, et al.. (2018). Heterogeneous nature of diabetes in a family with a gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene. Endocrine Journal. 65(10). 1055–1059. 12 indexed citations
6.
7.
Tanaka, Yuri, et al.. (2014). Overt Diabetes Mellitus Caused by the Topical Administration of Dexamethasone Ointment on the Oral Mucosa. Internal Medicine. 53(15). 1633–1635. 2 indexed citations
8.
Ichikawa, Tomomi, Hirokazu Taniguchi, Hisashi Sumiya, et al.. (2013). Mediastinal Thyroid Goiter with No Accumulation on Scintigraphy. Internal Medicine. 52(18). 2159–2159. 2 indexed citations
9.
Motoo, Iori, et al.. (2012). Autoimmune Polyglandular Syndrome Type 3 with Anorexia. SHILAP Revista de lepidopterología. 2012. 1–4. 2 indexed citations
10.
Ando, Hitoshi, Toshinari Takamura, Naoto Nagata, et al.. (2009). The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. Biochemical and Biophysical Research Communications. 380(3). 684–688. 22 indexed citations
11.
Ando, Hitoshi, Toshinari Takamura, Naoto Nagata, et al.. (2008). Clock gene expression in peripheral leucocytes of patients with type 2 diabetes. Diabetologia. 52(2). 329–335. 108 indexed citations
12.
Kuzuya, Takeshi, Shigeki Nakagawa, J. Satoh, et al.. (1999). Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus particularly higher risk to develop diabetes Diabetes-specific microvascular complications are rare but arteriosclerotic complications are fairly frequent in this category Gestational diabetes mellitus The current definition of GDM is any glucose intolerance developed or detected during pregnancy We adopt the proposal of the Japan Society of Gynecology and Obste. 42(5). 385–404. 5 indexed citations
13.
Murakami, Takashi & Kosuke R. Shima. (1995). [Diabetogenes; which cause type II diabetes mellitus].. PubMed. 43(8). 781–5. 2 indexed citations
14.
Matsuki, Nobuo, et al.. (1994). [A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].. PubMed. 21(15). 2659–62. 6 indexed citations
15.
Hara, Nobuyuki, Y. Ichinose, Mutsuo Kuba, et al.. (1994). A phase II study of cyclophosphamide / adriamycin / vincristine / etoposide (CAVE) alternating with cisplatin / etoposide (PE) in small cell lung cancer (SCLC). Lung Cancer. 11. 101–101. 2 indexed citations
16.
Ohta, Mitsuo, Naoko Hara, Yukari Ichikawa, et al.. (1988). [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].. PubMed. 15(6). 1901–8. 1 indexed citations
17.
Namba, Masashi, et al.. (1981). Release of Gut GLI by Luminal Hypotonicity. Hormone and Metabolic Research. 13(8). 471–472. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcus Simmgen Breakdown of academic impact, for papers by I‐Ya Chen Breakdown of academic impact, for papers by Shanee Chung Breakdown of academic impact, for papers by Joel K. Campbell Breakdown of academic impact, for papers by Anna‐Maria Siegert Breakdown of academic impact, for papers by N. Patano Breakdown of academic impact, for papers by CJ Strasburger Breakdown of academic impact, for papers by Zhiyi Song Breakdown of academic impact, for papers by Ana Carolina Proença da Fonseca Breakdown of academic impact, for papers by Jennifer Strong
Rankless by CCL
2026